P736: ANALYSIS OF RESPONSE RATES AND OUTCOMES IN ERYTHROID-PREDOMINANT MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH VENETOCLAX-BASED REGIMENS

• Alexandre Bazinet,
• Naszrin Arani,
• Kelly Chien,
• Danielle Hammond,
• Tapan Kadia,
• Gautam Borthakur,
• Yesid Alvarado,
• Koji Sasaki,
• Courtney Dinardo,
• Naveen Pemmaraju,
• Lucia Masarova,
• Nicholas Short,
• Musa Yilmaz,
• Naval Daver,
• Elias Jabbour,
• Farhad Ravandi,
• Rashmi Kanagal-Shamanna,
• Sherry Pierce,
• Hagop Kantarjian,
• Guillermo Garcia-Manero,
• Guillermo Montalban-Bravo

Affiliations

Alexandre Bazinet

1 MD Anderson Cancer Center, Houston, United States

Naszrin Arani

1 MD Anderson Cancer Center, Houston, United States

Kelly Chien

1 MD Anderson Cancer Center, Houston, United States

Danielle Hammond

1 MD Anderson Cancer Center, Houston, United States

Tapan Kadia

1 MD Anderson Cancer Center, Houston, United States

Gautam Borthakur

1 MD Anderson Cancer Center, Houston, United States

Yesid Alvarado

1 MD Anderson Cancer Center, Houston, United States

Koji Sasaki

1 MD Anderson Cancer Center, Houston, United States

Courtney Dinardo

1 MD Anderson Cancer Center, Houston, United States

Naveen Pemmaraju

1 MD Anderson Cancer Center, Houston, United States

Lucia Masarova

1 MD Anderson Cancer Center, Houston, United States

Nicholas Short

1 MD Anderson Cancer Center, Houston, United States

Musa Yilmaz

1 MD Anderson Cancer Center, Houston, United States

Naval Daver

1 MD Anderson Cancer Center, Houston, United States

Elias Jabbour

1 MD Anderson Cancer Center, Houston, United States

Farhad Ravandi

1 MD Anderson Cancer Center, Houston, United States

Rashmi Kanagal-Shamanna

1 MD Anderson Cancer Center, Houston, United States

Sherry Pierce

1 MD Anderson Cancer Center, Houston, United States

Hagop Kantarjian

1 MD Anderson Cancer Center, Houston, United States

Guillermo Garcia-Manero

1 MD Anderson Cancer Center, Houston, United States

Guillermo Montalban-Bravo

1 MD Anderson Cancer Center, Houston, United States